The city of Oakland, California, currently has 1 active clinical trials seeking participants for Pain research studies.
A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
Recruiting
This study is an open-label study to evaluate the safety of long-term administration of inclacumab in participants with sickle cell disease (SCD). Participants in this study will have completed a prior study of inclacumab.
Gender:
All
Ages:
12 years and above
Trial Updated:
03/13/2024
Locations: Children's Hospital and Research Center at Oakland, Oakland, California
Conditions: Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease